Brazil vs Trinidad and Tobago: HIV-positive TB patients on ART (antiretroviral therapy)
Brazil
59.0%
in 2024
Trinidad and Tobago
51.0%
in 2024
Brazil rank
136th
Trinidad and Tobago rank
139th
HIV-positive TB patients on ART (antiretroviral therapy) over time
- Brazil
- Trinidad and Tobago
How they compare
Brazil currently reports 59.0% against 51.0% in Trinidad and Tobago, a difference of 8.0%.
That makes Brazil's figure about 1.2 times Trinidad and Tobago's.
The two have swapped places 6 times across 20 shared years of data; in 2003 it was Brazil ahead.
Brazil ranks 136th and Trinidad and Tobago ranks 139th of 144 countries.
Across the 3 decades both report, Brazil averaged higher in 2 and Trinidad and Tobago in 1.
Head to head by decade
| Decade | Brazil | Trinidad and Tobago | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 92.4% | 41.6% | 50.8% | Brazil |
| 2010s | 66.9% | 39.8% | 27.1% | Brazil |
| 2020s | 56.0% | 81.0% | 25.0% | Trinidad and Tobago |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher hiv-positive tb patients on art (antiretroviral therapy), Brazil or Trinidad and Tobago?
- Brazil, at 59.0% against 51.0% in Trinidad and Tobago as of 2024.
- What is the difference in hiv-positive tb patients on art (antiretroviral therapy) between Brazil and Trinidad and Tobago?
- 8.0%, with Brazil ahead.
- How many years of comparable data are there for Brazil and Trinidad and Tobago?
- 20 years are reported by both, from 2003 to 2024.
- How do Brazil and Trinidad and Tobago rank globally for hiv-positive tb patients on art (antiretroviral therapy)?
- Brazil ranks 136th and Trinidad and Tobago ranks 139th of 144 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as HIV-positive TB patients on ART (antiretroviral therapy) (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.